Flu Pre-Epidemic Declared Early in Two French Regions; Expert Warns Holiday Disruption

Influenza surveillance in France flipped to pre-epidemic status in Île-de-France and Hauts-de-France on November 18, weeks ahead of the typical seasonal curve, according to Actu.

The declaration by Santé publique France arrived Wednesday, November 18, marking the earliest metropolitan pre-epidemic classification since the 2025–2026 wave began in early December 2025. That season ultimately recorded over 12,000 deaths and roughly 115,000 emergency department visits, with 21 percent requiring hospitalization, according to the agency’s retrospective report.

Two overseas territories, Guadeloupe and Martinique, are already further advanced, with Guadeloupe entering pre-epidemic phase and Martinique in full epidemic status for three weeks, Paris Match reported.

“It is not reported to my knowledge any worrying signals concerning flu this year,” epidemiologist Antoine Flahault told actu.fr. “The increase in circulation of seasonal influenza viruses remains very limited and very modest across the national territory, reported currently mainly in Hauts-de-France and Île-de-France.”

Two Mainland Regions Enter Steady Virus Spread

  • Two mainland regions have crossed the threshold where the virus is spreading steadily; the rest of France is above seasonal baselines but not yet in pre-epidemic phase.
  • Vaccination takes roughly two weeks to build protection; the current vaccine targets the dominant A(H1N1)pdm09 strain, though effectiveness against infection averages 40–50 percent.
  • Seniors in Île-de-France saw a 75 percent jump in SOS Médecins consultations and a 31 percent rise in ER visits during the week of November 9–15, Medisite.fr reported.

Virological Profile: A(H1N1)pdm09 Dominates

Laboratory data from the week of November 9–15 (week 46) show type A viruses dominating, with the A(H1N1)pdm09 subtype gaining ground over A(H3N2) and B/Victoria lineage strains, according to Santé publique France bulletins cited by Doctissimo and Medisite.fr. The WHO-coordinated northern hemisphere vaccine composition includes an A/Victoria/4897/2022-like (H1N1)pdm09 component, matching the circulating subclade.

“Generally the flu vaccine is not 100 percent effective against infection, but rather around 40 to 50 percent,” Flahault told actu.fr. “On the other hand, the effectiveness we seek and which justifies vaccination of the elderly and at-risk is effectiveness against severe forms leading to hospitalization.”

Vaccination Coverage Lags WHO Target

Approximately seven million doses had been sold by mid-November, a 3 percent drop versus the same period in 2025, Doctissimo reported. Coverage among those 65 and older hovers near 55 percent, well below the WHO’s 75 percent target. The UK, which reaches 75 percent coverage in seniors, sees epidemic magnitudes comparable to France, Flahault noted, showing that current vaccines limit severe outcomes more than transmission.

Flu Pre-Epidemic Declared Early in Two French Regions; Expert Warns Holiday Disruption
Photo: Paris Match
Season Hospitalizations Averted (65+) Total Flu Hospitalizations (65+)
2023–2024 8,315 ~44,000 avg
2024–2025 11,732 ~44,000 avg
2025–2026 7,145 ~44,000 avg

Since winter 2023–2024, vaccination has averted an annual average of 9,000 hospitalizations in adults 65 and older against a backdrop of roughly 44,000 flu hospitalizations per season in that age group, Paris Match reported, citing Santé publique France.

Santé publique France was created on 1 May 2016 under the Health System Modernization Law, merging the health surveillance institute InVS, the prevention institute Inpes, and the emergency preparedness body Éprus. The agency operates 15 regional intervention units across the territory and is governed by a 32-member board whose president is appointed by decree of the President of the Republic.

El Niño Signal Offers Modest Reassurance

High-Dose Vaccine Cuts Hospitalization Risk for Seniors

  • High-dose and adjuvanted formulations are preferred for adults 65+; a NEJM study cited by Medisite.fr showed the high-dose vaccine reduced hospitalization risk by 43.6 percent versus standard-dose in this cohort.

“The end-of-year holidays could be a little disrupted for some of us by the flu,” Flahault told actu.fr. “One can fear tension in hospitals during the two weeks surrounding the epidemic peak, if the epidemic is of significant magnitude.”

References

  • Santé publique France, Bulletin hebdomadaire grippe, semaine 46 (November 9–15, 2026)
  • World Health Organization, Recommended composition of influenza virus vaccines for use in the 2026–2027 northern hemisphere influenza season
  • DiazGranados CA et al. “Efficacy of High-Dose versus Standard-Dose Influenza Vaccine in Older Adults.” New England Journal of Medicine, 2024
  • Flahault A. Interview with actu.fr, published November 19, 2026
  • Cour des comptes, Rapport sur la politique de vaccination, 2026

Photo of author

Health Desk

Health Desk at Archyde.

China’s October Imports Surge 41.6% but EU Shipments Fall 4.2%, Customs Data Shows